Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression

9 Sept 2009

Abstract excerpt

The search for a classic biomarker for prostate cancer has been on for a very long time, and it is still elusive. Despite the extensive and prolonged use of the prostate-specific antigen (PSA) as a screening tool for prostate cancer, many clinicians still identify its limitations in the grading of tumors, and monitoring of response to treatment. These limitations are based on the concealment of cancer by low...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19891595
DOI: 10.2174/187221509789318360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer ProgressionPMID 19891595Read ↗

Molecular genetics of prostate cancer: clinical translational opportunities.Semantic proximity Read ↗

Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patientsSemantic proximity Read ↗

Molecular diagnosis of prostate cancer: are we up to age?Semantic proximity Read ↗

Prostate cancer – a biomarker perspectiveSemantic proximity Read ↗

Genetic alterations in prostate cancer as diagnostic and prognostic markers.Semantic proximity Read ↗

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsSemantic proximity Read ↗

The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementSemantic proximity Read ↗

Genetic factors underlying prostate cancer.Semantic proximity Read ↗

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerSemantic proximity Read ↗

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic TargetsSemantic proximity Read ↗

Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.Semantic proximity Read ↗

Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.